Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.2M; returns 1 day -4.1%, 1 week +1.4%, 1 year -80.9%.

Enveric Biosciences Inc. is a pre-commercial biotechnology company focused on developing next-generation, small-molecule neuroplastogenic therapeutics for psychiatric and neurological disorders.

Groups ENVB belongs to

• Biotechnology
• Recent Reverse Splits
• Neuroscience
• CNS Disorders
• Clinical Stage Biotech
• Drug Discovery
• Mental Health Solutions
• Pharmaceuticals
• Artificial Intelligence
• Healthcare Technology
• AI in Healthcare
• Neurological Disorders
• Biopharmaceutical

ENVB financial model: income statement, cash flow and balance sheet